Losartan Potassium Patent Expiration

Losartan Potassium was first introduced by Organon Llc A Sub Of Organon And Co in its drug Cozaar on Apr 14, 1995. Another drug containing Losartan Potassium is Arbli. 26 different companies have introduced drugs containing Losartan Potassium.


Losartan Potassium Patents

Given below is the list of patents protecting Losartan Potassium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Arbli US11890273 Losartan liquid formulations and methods of use Oct 07, 2041 Scienture
Arbli US12156869 Losartan liquid formulations and methods of use Oct 07, 2041 Scienture



Losartan Potassium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Losartan Potassium Generic API Manufacturers

Several generic applications have been filed for Losartan Potassium. The first generic version for Losartan Potassium was by Teva Pharmaceuticals Usa Inc and was approved on Apr 6, 2010. And the latest generic version is by Apotex Inc and was approved on Jun 4, 2024.

Given below is the list of companies who have filed for Losartan Potassium generic, along with the locations of their manufacturing plants worldwide.